Intellia Therapeutics Announces First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Intellia Therapeutics Announces First Quarter 2020 Financial Results

Intellia Therapeutics (NTLA) Misses Q1 EPS by 19c, Revenues Miss

May 7, 2020 7:44 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($0.63), $0.19 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.92 million versus the consensus estimate of $18.14 million.

At Intellia, our mission is to develop curative, CRISPR/Cas9-based treatments for severe diseases. I am... More